The global medical cannabis company is set to acquire Pharmadrug GmbH from its parent company, PharmaDrug Inc.
The sales estimates were based on a survey of research firms covering the financial outlook of Aurora.
The global market is likely to rise at a CAGR of 26.6 per cent from 2019 to 2027.
The funding round was led by Europe’s first cannabis and psychedelics fund, Leafy Tunnel.
Cannabis lender Chicago Atlantic had its IPO in December 2021 after four years as a private company.
The acquisition sees BLAZE expand to Canada as part of a strategic move to enter a federally regulated market.
The cannabis producer's stock shot up by 215 per cent on its first day of trading followed by a further 91 per cent increase yesterday.
Companies across the cannabis industry announce financial results for the first quarter of 2022, Cannabis Wealth rounds up the results of six major firms expanding within...
Lucid Green has announced three new partnerships to support the digitisation of certificates of analysis (COA).
Curaleaf's current CEO Joe Bayern will launch and run a new division of Curaleaf.